Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 01, 2022 07:46 ET | Source: Liquidia Corporation

Liquidia Announces the Publication of Long-Term Clinical Data from Completed INSPIRE Study in the Journal Pulmonary Circulation

Evaluated doses of YUTREPIA™ (treprostinil) inhalation powder from 26.5 mcg to 212 mcg which are comparable to 3 to 24 breaths of nebulized Tyvaso® per sessionAchieved therapeutic levels by Month 2...
August 01, 2022 06:24 ET | Source: Liquidia Corporation

Liquidia to Participate in Upcoming Investor Conferences

MORRISVILLE, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will be participating at the following investor conferences next week: BTIG...
July 25, 2022 08:51 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common...
July 21, 2022 16:30 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., July 21, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that, in connection with the previously announced appointment of Rajeev Saggar, M.D.,...
July 19, 2022 16:30 ET | Source: Liquidia Corporation

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

MORRISVILLE, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes...
June 27, 2022 06:26 ET | Source: Liquidia Corporation

Liquidia Corporation Added to Russell 2000® and 3000® Indexes

MORRISVILLE, N.C., June 27, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company was added as a member of the US small-cap Russell 2000® Index, effective...
June 24, 2022 16:15 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 24,800 shares of...
June 24, 2022 09:35 ET | Source: Liquidia Corporation

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common...
June 20, 2022 07:00 ET | Source: Liquidia Corporation

Liquidia Appoints Rajeev Saggar, M.D., as Chief Medical Officer

MORRISVILLE, N.C., June 20, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the appointment of Rajeev Saggar, M.D., to the position of...
June 09, 2022 16:30 ET | Source: Liquidia Corporation

Liquidia Announces Presentation at the 2022 Pulmonary Hypertension Association (PHA) International Conference

MORRISVILLE, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the presentation of data related to the investigational use of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right